Alimera Sciences Net debt/EBITDA
What is the Net debt/EBITDA of Alimera Sciences?
The Net debt/EBITDA of Alimera Sciences Inc. is -46.51
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with net debt/ebitda similar to Alimera Sciences
- Inca One Gold has Net debt/EBITDA of -47.04
- Journeo plc has Net debt/EBITDA of -46.99
- McBride Plc has Net debt/EBITDA of -46.99
- Raise Production has Net debt/EBITDA of -46.96
- Summer Infant Inc has Net debt/EBITDA of -46.90
- Majestic Wine Plc has Net debt/EBITDA of -46.57
- Alimera Sciences has Net debt/EBITDA of -46.51
- Husky has Net debt/EBITDA of -46.47
- Hydoo International has Net debt/EBITDA of -46.45
- Partner Jet has Net debt/EBITDA of -46.32
- China Wan Tong Yuan () has Net debt/EBITDA of -46.19
- Trafalgar Property plc has Net debt/EBITDA of -46.15
- Astronics has Net debt/EBITDA of -46.11